Randomized comparative study of cisplatin, docetaxel, and irinotecan versus cisplatin and docetaxel in patients with stage IIIB or stage IV non-small cell lung cancer (OLCSG 0403)
Phase 3
- Conditions
- Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- Registration Number
- JPRN-C000000205
- Lead Sponsor
- Okayama Lung Cancer Study Group (OLCSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1. Symptomatic brain metastasis 2. Active concomittant malignancy, history of previous chemotherapy or thoracic radiation therapy for malignancy 3. Clinically significant allergic history 4. Pregnant or lactating women 5. Severe comrbidities 1) Active interstial pneumonia 2) Unstable angina pectoris, or recent history of myocardial infarction 3) Uncntrolled diabetes mellitus 4) Sever active infection 5) Pleural effusion or ascites which require treatment 6) Clinically significant pericardial effusion 7) Other clinical condition which is considered as inappropriate for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method